Jiye Liu

Aug 14, 2024 | mdpi.com | Xiao Yan |Xionghui Qiu |Zhen Yao |Jiye Liu

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Sep 30, 2023 | onclive.com | Jiye Liu

Jiye Liu, PhD, instructor in medicine, Department of Medicine, Dana-Farber Cancer Institute, discusses epigenetic regulation of CD38/CD48 in multiple myeloma. Daratumumab (Darzalex) is an anti-CD38 monoclonal antibody used in the treatment of patients with newly diagnosed and relapsed/refractory multiple myeloma.